Comparison of the incidence and organ distribution of acute graft-versus-host disease following allogeneic stem cell transplantation in japanese patients receiving bone marrow (BM) or peripheral blood stem cells (PBSC)

Akiko Saito, Yoshinobu Kanda, Takeshi Saito, Ryuji Tanosaki, Shin Mineishi

Research output: Contribution to journalArticle

Abstract

Recently, PBSC have become more frequently used in place of BM as a source of allogeneic hematopoietic stem cell transplantation. PBSC samples contain greater number of both progenitors and lymphocytes compared to BM. Several studies have shown that the incidence of acute GVHD (aGVHD) is similar between PBSCT and BMT. However, it must also be compared in Japanese recipients, because it has been known that the incidence of aGVHD is lower and the character of aGVHD may be different in BM recipients in Japan compared to those in European/American countries. In addition, it has not been clarified whether the organ distribution of acute GVHD is altered by the use of PBSC. In order to evaluate these issues, we compared the clinical courses of 28 PBSC recipients with those of 27 BM recipients who received allogeneic HSCT at NCCH between 1996 and 2000. All received allogeneic graft from an HLA-identical sibling or a relative with one HLAmismatched antigen for the underlying hematological malignancies. The median age was 40 years in PBSC recipients and 37 years in BM recipients. The preparative regimen was busulfan-based regimen or TBI-based regimen. Prophylaxis for GVHD was performed with cyclosporine A and short-term methotrexate. Twenty-five of 27 BM recipients and all 28 PBSC recipients had engraftment and enrolled in the following analyses. The frequency of grade II-IV acute GVHD after transplantation was 46% in PBSC recipients and 36% in BM recipients (p=0.442). The onset of acute GVHD and the severity of acute GVHD were not significantly different (p=0.60I and 0.312, respectively). Next, we evaluated the organ distribution of acute GVHD by analyzing the incidence of acute GVHD in the skin, gut, and liver lesions separately, with no significant difference (skin p=0.305, gut p=0.730, liver p=0.650). In conclusion, we could not detect any significant difference in the incidences of acute GVHD or its organ distribution between allogeneic BM and PBSC recipients in Japan. However, a prospective randomized study with a larger number of patients is still required to clarify this issue.

Original languageEnglish (US)
JournalBlood
Volume96
Issue number11 PART II
StatePublished - Dec 1 2000

Fingerprint

Transplantation (surgical)
Stem Cell Transplantation
Graft vs Host Disease
Stem cells
Grafts
Bone
Blood
Bone Marrow
Incidence
Liver
Japan
Skin
Busulfan
Peripheral Blood Stem Cells
Hematopoietic Stem Cell Transplantation
Hematologic Neoplasms
Lymphocytes
Methotrexate
Cyclosporine
Siblings

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

@article{37286ced87b848ed8f53430515ddfbe1,
title = "Comparison of the incidence and organ distribution of acute graft-versus-host disease following allogeneic stem cell transplantation in japanese patients receiving bone marrow (BM) or peripheral blood stem cells (PBSC)",
abstract = "Recently, PBSC have become more frequently used in place of BM as a source of allogeneic hematopoietic stem cell transplantation. PBSC samples contain greater number of both progenitors and lymphocytes compared to BM. Several studies have shown that the incidence of acute GVHD (aGVHD) is similar between PBSCT and BMT. However, it must also be compared in Japanese recipients, because it has been known that the incidence of aGVHD is lower and the character of aGVHD may be different in BM recipients in Japan compared to those in European/American countries. In addition, it has not been clarified whether the organ distribution of acute GVHD is altered by the use of PBSC. In order to evaluate these issues, we compared the clinical courses of 28 PBSC recipients with those of 27 BM recipients who received allogeneic HSCT at NCCH between 1996 and 2000. All received allogeneic graft from an HLA-identical sibling or a relative with one HLAmismatched antigen for the underlying hematological malignancies. The median age was 40 years in PBSC recipients and 37 years in BM recipients. The preparative regimen was busulfan-based regimen or TBI-based regimen. Prophylaxis for GVHD was performed with cyclosporine A and short-term methotrexate. Twenty-five of 27 BM recipients and all 28 PBSC recipients had engraftment and enrolled in the following analyses. The frequency of grade II-IV acute GVHD after transplantation was 46{\%} in PBSC recipients and 36{\%} in BM recipients (p=0.442). The onset of acute GVHD and the severity of acute GVHD were not significantly different (p=0.60I and 0.312, respectively). Next, we evaluated the organ distribution of acute GVHD by analyzing the incidence of acute GVHD in the skin, gut, and liver lesions separately, with no significant difference (skin p=0.305, gut p=0.730, liver p=0.650). In conclusion, we could not detect any significant difference in the incidences of acute GVHD or its organ distribution between allogeneic BM and PBSC recipients in Japan. However, a prospective randomized study with a larger number of patients is still required to clarify this issue.",
author = "Akiko Saito and Yoshinobu Kanda and Takeshi Saito and Ryuji Tanosaki and Shin Mineishi",
year = "2000",
month = "12",
day = "1",
language = "English (US)",
volume = "96",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11 PART II",

}

Comparison of the incidence and organ distribution of acute graft-versus-host disease following allogeneic stem cell transplantation in japanese patients receiving bone marrow (BM) or peripheral blood stem cells (PBSC). / Saito, Akiko; Kanda, Yoshinobu; Saito, Takeshi; Tanosaki, Ryuji; Mineishi, Shin.

In: Blood, Vol. 96, No. 11 PART II, 01.12.2000.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of the incidence and organ distribution of acute graft-versus-host disease following allogeneic stem cell transplantation in japanese patients receiving bone marrow (BM) or peripheral blood stem cells (PBSC)

AU - Saito, Akiko

AU - Kanda, Yoshinobu

AU - Saito, Takeshi

AU - Tanosaki, Ryuji

AU - Mineishi, Shin

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Recently, PBSC have become more frequently used in place of BM as a source of allogeneic hematopoietic stem cell transplantation. PBSC samples contain greater number of both progenitors and lymphocytes compared to BM. Several studies have shown that the incidence of acute GVHD (aGVHD) is similar between PBSCT and BMT. However, it must also be compared in Japanese recipients, because it has been known that the incidence of aGVHD is lower and the character of aGVHD may be different in BM recipients in Japan compared to those in European/American countries. In addition, it has not been clarified whether the organ distribution of acute GVHD is altered by the use of PBSC. In order to evaluate these issues, we compared the clinical courses of 28 PBSC recipients with those of 27 BM recipients who received allogeneic HSCT at NCCH between 1996 and 2000. All received allogeneic graft from an HLA-identical sibling or a relative with one HLAmismatched antigen for the underlying hematological malignancies. The median age was 40 years in PBSC recipients and 37 years in BM recipients. The preparative regimen was busulfan-based regimen or TBI-based regimen. Prophylaxis for GVHD was performed with cyclosporine A and short-term methotrexate. Twenty-five of 27 BM recipients and all 28 PBSC recipients had engraftment and enrolled in the following analyses. The frequency of grade II-IV acute GVHD after transplantation was 46% in PBSC recipients and 36% in BM recipients (p=0.442). The onset of acute GVHD and the severity of acute GVHD were not significantly different (p=0.60I and 0.312, respectively). Next, we evaluated the organ distribution of acute GVHD by analyzing the incidence of acute GVHD in the skin, gut, and liver lesions separately, with no significant difference (skin p=0.305, gut p=0.730, liver p=0.650). In conclusion, we could not detect any significant difference in the incidences of acute GVHD or its organ distribution between allogeneic BM and PBSC recipients in Japan. However, a prospective randomized study with a larger number of patients is still required to clarify this issue.

AB - Recently, PBSC have become more frequently used in place of BM as a source of allogeneic hematopoietic stem cell transplantation. PBSC samples contain greater number of both progenitors and lymphocytes compared to BM. Several studies have shown that the incidence of acute GVHD (aGVHD) is similar between PBSCT and BMT. However, it must also be compared in Japanese recipients, because it has been known that the incidence of aGVHD is lower and the character of aGVHD may be different in BM recipients in Japan compared to those in European/American countries. In addition, it has not been clarified whether the organ distribution of acute GVHD is altered by the use of PBSC. In order to evaluate these issues, we compared the clinical courses of 28 PBSC recipients with those of 27 BM recipients who received allogeneic HSCT at NCCH between 1996 and 2000. All received allogeneic graft from an HLA-identical sibling or a relative with one HLAmismatched antigen for the underlying hematological malignancies. The median age was 40 years in PBSC recipients and 37 years in BM recipients. The preparative regimen was busulfan-based regimen or TBI-based regimen. Prophylaxis for GVHD was performed with cyclosporine A and short-term methotrexate. Twenty-five of 27 BM recipients and all 28 PBSC recipients had engraftment and enrolled in the following analyses. The frequency of grade II-IV acute GVHD after transplantation was 46% in PBSC recipients and 36% in BM recipients (p=0.442). The onset of acute GVHD and the severity of acute GVHD were not significantly different (p=0.60I and 0.312, respectively). Next, we evaluated the organ distribution of acute GVHD by analyzing the incidence of acute GVHD in the skin, gut, and liver lesions separately, with no significant difference (skin p=0.305, gut p=0.730, liver p=0.650). In conclusion, we could not detect any significant difference in the incidences of acute GVHD or its organ distribution between allogeneic BM and PBSC recipients in Japan. However, a prospective randomized study with a larger number of patients is still required to clarify this issue.

UR - http://www.scopus.com/inward/record.url?scp=33748556539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748556539&partnerID=8YFLogxK

M3 - Article

VL - 96

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11 PART II

ER -